Gestational Diabetes Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Gestational Diabetes Market is segmented By Treatment (Insulin Therapy, Rapid-Acting Insulin, Short-Acting Insulin, Intermediate-Acting Insulin, Long-Acting Insulin, Oral ....

Gestational Diabetes Market Size

Market Size in USD

CAGR8.9%

Study Period2024 - 2031
Base Year of Estimation2023
CAGR8.9%
Market ConcentrationMedium
Major PlayersNovo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Co., Inc., F. Hoffmann-La Roche Ltd
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
setting-icon
Want to purchase customized report?
please let us know !

Gestational Diabetes Market Analysis

The gestational diabetes market is estimated to be valued at USD 9.4 Bn in 2024 and is expected to reach USD 17.1 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.9% from 2024 to 2031. An increasing number of risk factors associated with gestational diabetes such as rising obesity levels, older maternal age during pregnancy and sedentary lifestyles are contributing to the rising disease incidence. However, the lack of symptoms in early stages of gestational diabetes remains a major challenge.